Patents by Inventor Chantal Dax

Chantal Dax has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090137532
    Abstract: The invention relates to novel aldolase-inhibiting compounds that can be advantageously used as medicaments (in therapeutic doses), especially for treating certain cancers, due to the inhibition efficacy thereof. An inventive compound corresponds to general formula (I) wherein the aldehyde group (—CHO) and the phenol group (—OH) are linked to two carbon atoms adjacent to the same aromatic chain, i.e., the first aromatic chain, and R is a phosphate group or a phosphate group mimetic linked to a carbon atom of the second aromatic chain.
    Type: Application
    Filed: November 6, 2008
    Publication date: May 28, 2009
    Applicants: VALORISATION-RECHERCHE, LIMITED PARTNERSHIP, UNIVERSITE PAUL SABATIER TOULOUSE III
    Inventors: Chantal Dax, Casimir Blonski, Laurent Azema, Jurgen Sygusch
  • Patent number: 7470821
    Abstract: The invention relates to novel aldolase-inhibiting compounds that can be advantageously used as medicaments (in therapeutic doses), especially for treating certain cancers, due to the inhibition efficacy thereof. An inventive compound corresponds to general formula (I) wherein the aldehyde group (—CHO) and the phenol group (—OH) are linked to two carbon atoms adjacent to the same aromatic chain, i.e., the first aromatic chain, and R is a phosphate group or a phosphate group mimetic linked to a carbon atom of the second aromatic chain.
    Type: Grant
    Filed: June 29, 2004
    Date of Patent: December 30, 2008
    Assignees: Valorisation-Recherche, Limited Partnership, Universite Paul Sabatier Toulouse III
    Inventors: Chantal Dax, Casimir Blonski, Laurent Azema, Jurgen Sygusch
  • Publication number: 20070043002
    Abstract: The invention relates to novel aldolase-inhibiting compounds that can be advantageously used as medicaments (in therapeutic doses), especially for treating certain cancers, due to the inhibition efficacy thereof. An inventive compound corresponds to general formula (I) wherein the aldehyde group (—CHO) and the phenol group (—OH) are linked to two carbon atoms adjacent to the same aromatic chain, i.e., the first aromatic chain, and R is a phosphate group or a phosphate group mimetic linked to a carbon atom of the second aromatic chain.
    Type: Application
    Filed: June 29, 2004
    Publication date: February 22, 2007
    Inventors: Chantal Dax, Casimir Blonski, Laurent Azema, Jurgen Sygusch